Çмú´ëȸ ¹ßÇ¥ ¿¬Á¦ ÃÊ·Ï

¹ßÇ¥Çü½Ä : Æ÷½ºÅÍ(Àü½Ã) Á¢¼ö¹øÈ£ - 980018    OTPX-19 
BONE DESTRUCTION IN CHRONIC OTITIS MEDIA IS NOT MEDIATED BY THE RANKL PATHWAY OR ESTROGEN RECEPTOR-ALPHA
1 DEPARTMENT OF OTORHINOLARYNGOLOGY-HEAD & NECK SURGERY, BUSAN PAIK HOSPITAL, BUSAN, SOUTH KOREA, 2 ANATOMY AND RESEARCH CENTER FOR TUMOR IMMUNOLOGY INJE UNIVERSITY COLLEGE OF MEDICINE, BUSAN PAIK HOSPITAL, BUSAN, SOUTH KOREA
WOO JIN KIM, KYUNG WOOK HEO1 , MINHYE NOH2 , DAE YOUNG HUR2 , TAE UI HONG1 , SUNG YOOL PARK1 AND WOO JIN KIM1
¸ñÀû: Chronic otitis media with or without cholesteatoma progresses with various degrees of bone resorption and remodeling. Estrogen mediates osteoprotective effects through the receptor activator of NF-¥êB ligand (RANKL) pathway, which is mainly mediated by estrogen receptor- alpha (ER-¥á). The present study investigated the expression patterns of receptor activator of NF¥êB (RANK), osteoprotegerin (OPG), RANKL, and ER-¥á in pathological tissue from patients with chronic otitis media to determine the roles of those factors in osteolytic mechanisms underlying the pathogenesis of chronic otitis media. ¹æ¹ý:Normal and pathological specimens from 18 patients with chronic otitis media were examined. °á°ú:There were no significant differences in RANK, OPG, RANKL, or ER-¥á mRNA expression between normal and pathological specimens of epithelial tissue °á·Ð:Our findings suggested that RANK, OPG, RANKL, and ER-¥á are not associated with the bone destruction in chronic otitis media; other cytokines may directly activate the osteoclasts in chronic otitis media.


[´Ý±â]